Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has added new features for data download options, while several key government health-related links have been removed.SummaryDifference14%
- Check22 days agoChange DetectedNew resources added from HHS, NIH, NLM, NCBI, and USA.gov, while a previous entry was removed on December 15, 2023.SummaryDifference2%
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options for data in various formats (CSV, JSON, RIS, FHIR) and allowing users to select specific fields for download.SummaryDifference16%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.6%
Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.